69 related articles for article (PubMed ID: 2381052)
1. [Immunohistochemical studies of collagen types I, III and IV distribution and the expression of procollagen III peptide in papillary carcinomas of the thyroid].
Katoh R; Ono S; Sasaki J; Takayama K; Nishio H; Tomichi N; Yagawa K
Gan No Rinsho; 1990 Aug; 36(9):967-72. PubMed ID: 2381052
[TBL] [Abstract][Full Text] [Related]
2. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas.
Di Pasquale M; Rothstein JL; Palazzo JP
Hum Pathol; 2001 Jan; 32(1):24-30. PubMed ID: 11172291
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.
Kato M; Maeta H; Kato S; Shinozawa T; Terada T
Mod Pathol; 2000 Oct; 13(10):1060-5. PubMed ID: 11048798
[TBL] [Abstract][Full Text] [Related]
5. Type IIA procollagen in development of the human intervertebral disc: regulated expression of the NH(2)-propeptide by enzymic processing reveals a unique developmental pathway.
Zhu Y; McAlinden A; Sandell LJ
Dev Dyn; 2001 Apr; 220(4):350-62. PubMed ID: 11307168
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of c-met protein in papillary thyroid carcinoma.
Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
Huang SM; Lee JC; Wu TJ; Chow NH
World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
[TBL] [Abstract][Full Text] [Related]
11. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer.
Kebebew E; Treseler PA; Duh QY; Clark OH
Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323
[TBL] [Abstract][Full Text] [Related]
12. Aberrant type I and type III collagen gene expression in human breast cancer in vivo.
Kauppila S; Stenbäck F; Risteli J; Jukkola A; Risteli L
J Pathol; 1998 Nov; 186(3):262-8. PubMed ID: 10211114
[TBL] [Abstract][Full Text] [Related]
13. [Property of scirrhous carcinoma of the stomach defined by collagen metabolism].
Niitsu Y; Ito N; Owada M; Morita K; Matsuura K; Kohgo Y; Urushizaki I
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1229-35. PubMed ID: 2837982
[TBL] [Abstract][Full Text] [Related]
14. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
[TBL] [Abstract][Full Text] [Related]
15. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
17. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
18. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
[TBL] [Abstract][Full Text] [Related]
19. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma.
Shi Y; Parhar RS; Zou M; Hammami MM; Akhtar M; Lum ZP; Farid NR; Al-Sedairy ST; Paterson MC
Br J Cancer; 1999 Mar; 79(7-8):1234-9. PubMed ID: 10098765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]